会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Hybrid suppressor tRNA for vertebrate cells
    • 用于脊椎动物细胞的杂交抑制子tRNA
    • US09133495B2
    • 2015-09-15
    • US12440015
    • 2007-09-07
    • Feng TianThea NormanStephanie Chu
    • Feng TianThea NormanStephanie Chu
    • C12N15/85C12P21/02C12N9/00C12N15/11
    • C12P21/02C12N9/93C12N15/11
    • This invention provides compositions and methods for producing translational components that expand the number of genetically encoded amino acids in vertebrate cells. The components include orthogonal tRNA's, orthogonal aminoacyl-tRNA synthetases, orthogonal pairs of tRNA's/synthetases and unnatural amino acids. Proteins and methods of producing proteins with unnatural amino acids in vertebrate cells are also provided. The present invention provides vertebrate cells with translation components, e.g., pairs of orthogonal aminoacyl-tRNA synthetases (O-RSs) and orthogonal tRNA's (O-tRNA's) and individual components thereof, that are used in vertebrate protein biosynthetic machinery to incorporate an unnatural amino acid in a growing polypeptide chain, in a vertebrate cell.
    • 本发明提供用于生产翻译成分的组合物和方法,其扩展脊椎动物细胞中遗传编码氨基酸的数目。 组分包括正交tRNA,正交氨酰-tRNA合成酶,tRNA /合成酶和非天然氨基酸的正交对。 还提供了在脊椎动物细胞中产生具有非天然氨基酸的蛋白质的蛋白质和方法。 本发明提供具有翻译成分的脊椎动物细胞,例如正交氨基-tRNA合成酶(O-RS)和正交tRNA(O-tRNA)及其各自成分的对,其用于脊椎动物蛋白质生物合成机制以掺入非天然氨基 在生长的多肽链中,在脊椎动物细胞中。
    • 3. 发明授权
    • Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
    • 含有,涉及非天然氨基酸和多肽的方法和使用的组合物
    • US08557781B2
    • 2013-10-15
    • US11925732
    • 2007-10-26
    • Zhenwei MiaoJunjie LiuThea Norman
    • Zhenwei MiaoJunjie LiuThea Norman
    • C07K7/00A61K38/04A61K38/18
    • C07K2/00C07C229/42C07K1/006
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one aromatic amine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one alkylated amine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括广泛范围的可能的官能团,但典型地具有至少一个芳族胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个烷基化胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 8. 发明申请
    • COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
    • 包含的组合物,涉及的方法和非天然氨基酸和多肽的用途
    • US20120315686A1
    • 2012-12-13
    • US13467870
    • 2012-05-09
    • Zhenwei MIAOJunjie LiuThea Norman
    • Zhenwei MIAOJunjie LiuThea Norman
    • C07K14/61C12N7/00C07K16/00C07K14/47C12N9/96
    • C07K2/00C07C229/42C07K1/006
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one aromatic amine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one alkylated amine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括广泛范围的可能的官能团,但典型地具有至少一个芳族胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个烷基化胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 10. 发明授权
    • Methods and compositions for the treatment of gastrointestinal disorders
    • 用于治疗胃肠道疾病的方法和组合物
    • US08110553B2
    • 2012-02-07
    • US12788979
    • 2010-05-27
    • Mark G. CurrieShalina Mahajan-MiklosG. Todd MilneThea Norman
    • Mark G. CurrieShalina Mahajan-MiklosG. Todd MilneThea Norman
    • A61K38/10
    • C07K7/08C07K14/245
    • The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
    • 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症(例如胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),克罗恩病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良( 包括功能性消化不良或非溃疡性消化不良),胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻)以及与便秘相关的疾病和病症,例如与使用阿片类止痛药相关的便秘,手术后便秘 肠梗阻)和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C(GC-C)受体的肽和其它试剂的其他病症和病症。